Washington, D.C. ( July 23, 2019) -- Combating unreasonable, unilateral drug price hikes is a big talking point on the presidential campaign trail. But when lawmakers asked the Federal Trade Commission about whether it could help, the commissioners — on a 3-2 party-line vote — said the agency lacks the authority. ...